AAAAAA

   
Results: 1-8 |
Results: 8
ONYX-015, AN E1B GENE-ATTENUATED ADENOVIRUS, CAUSES TUMOR-SPECIFIC CYTOLYSIS AND ANTITUMORAL EFFICACY THAT CAN BE AUGMENTED BY STANDARD CHEMOTHERAPEUTIC-AGENTS
Authors: HEISE C SAMPSONJOHANNES A WILLIAMS A MCCORMICK F VONHOFF DD KIRN DH
Citation: C. Heise et al., ONYX-015, AN E1B GENE-ATTENUATED ADENOVIRUS, CAUSES TUMOR-SPECIFIC CYTOLYSIS AND ANTITUMORAL EFFICACY THAT CAN BE AUGMENTED BY STANDARD CHEMOTHERAPEUTIC-AGENTS, Nature medicine, 3(6), 1997, pp. 639-645
LONG-TERM FREEDOM FROM DISEASE PROGRESSION WITH INTERFERON-ALFA THERAPY IN 2 PATIENTS WITH MALIGNANT HEMANGIOPERICYTOMA
Authors: KIRN DH KRAMER A
Citation: Dh. Kirn et A. Kramer, LONG-TERM FREEDOM FROM DISEASE PROGRESSION WITH INTERFERON-ALFA THERAPY IN 2 PATIENTS WITH MALIGNANT HEMANGIOPERICYTOMA, Journal of the National Cancer Institute, 88(11), 1996, pp. 764-765
REPLICATING VIRUSES AS SELECTIVE CANCER THERAPEUTICS
Authors: KIRN DH MCCORMICK F
Citation: Dh. Kirn et F. Mccormick, REPLICATING VIRUSES AS SELECTIVE CANCER THERAPEUTICS, Molecular medicine today, 2(12), 1996, pp. 519-527
SERUM FERRITIN LEVELS CORRELATE WITH DISEASE-ACTIVITY IN PATIENTS WITH AIDS AND DISSEMINATED HISTOPLASMOSIS
Authors: KIRN DH FREDERICKS D MCCUTCHAN JA STITES D SHUMAN M
Citation: Dh. Kirn et al., SERUM FERRITIN LEVELS CORRELATE WITH DISEASE-ACTIVITY IN PATIENTS WITH AIDS AND DISSEMINATED HISTOPLASMOSIS, Clinical infectious diseases, 21(4), 1995, pp. 1048-1049
MARKED ELEVATION OF THE SERUM FERRITIN IS HIGHLY SPECIFIC FOR DISSEMINATED HISTOPLASMOSIS IN AIDS
Authors: KIRN DH FREDERICKS D MCCUTCHAN JA STITES D SHUMAN M
Citation: Dh. Kirn et al., MARKED ELEVATION OF THE SERUM FERRITIN IS HIGHLY SPECIFIC FOR DISSEMINATED HISTOPLASMOSIS IN AIDS, AIDS, 9(10), 1995, pp. 1204-1205
SERUM FERRITIN LEVELS CORRELATE WITH DISEASE-ACTIVITY IN AIDS PATIENTS WITH DISSEMINATED HISTOPLASMOSIS (DH)
Authors: KIRN DH FREDERICKS D MCCUTCHAN JA STITES D SHUMAN M
Citation: Dh. Kirn et al., SERUM FERRITIN LEVELS CORRELATE WITH DISEASE-ACTIVITY IN AIDS PATIENTS WITH DISSEMINATED HISTOPLASMOSIS (DH), Blood, 84(10), 1994, pp. 10000702-10000702
EFFICACY OF DIFFERENT DOSING REGIMENS FOR RECOMBINANT-HUMAN-ERYTHROPOIETIN IN A SIMULATED PERISURGICAL SETTING - THE IMPORTANCE OF IRON AVAILABILITY IN OPTIMIZING RESPONSE
Authors: RUTHERFORD CJ SCHNEIDER TJ DEMPSEY H KIRN DH BRUGNARA C GOLDBERG MA
Citation: Cj. Rutherford et al., EFFICACY OF DIFFERENT DOSING REGIMENS FOR RECOMBINANT-HUMAN-ERYTHROPOIETIN IN A SIMULATED PERISURGICAL SETTING - THE IMPORTANCE OF IRON AVAILABILITY IN OPTIMIZING RESPONSE, The American journal of medicine, 96(2), 1994, pp. 139-145
MULTIMODALITY THERAPY OF PATIENTS WITH STAGE-IIIA, N2 NON-SMALL-CELL LUNG-CANCER - IMPACT OF PREOPERATIVE CHEMOTHERAPY ON RESECTABILITY ANDDOWNSTAGING
Authors: KIRN DH LYNCH TJ MENTZER SJ LEE TH STRAUSS GM ELIAS AD SKARIN AT SUGARBAKER DJ
Citation: Dh. Kirn et al., MULTIMODALITY THERAPY OF PATIENTS WITH STAGE-IIIA, N2 NON-SMALL-CELL LUNG-CANCER - IMPACT OF PREOPERATIVE CHEMOTHERAPY ON RESECTABILITY ANDDOWNSTAGING, Journal of thoracic and cardiovascular surgery, 106(4), 1993, pp. 696-702
Risultati: 1-8 |